← Leaderboards
Raymond Quezon Migrino
Medical College Of Wisconsin
$1,515,059
Attributed
$1,924,566
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $851.7K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,924,566 · 6
VA$0 · 3
By mechanism
R21$1,451,001 · 4
R56$471,635 · 1
M01$1,930 · 1
I01$0 · 3
Top collaborators
- Jonathan Lifshitz5 shared
- Ming Li2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David R Harder$18,930,514
- Richard J Roman$24,830,808
- Raymond C Koehler$25,438,173
- Paulo A. Ferreira$5,860,712
- David D. Gutterman$10,700,543
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBlood VesselsS DiseaseVascular DiseasesExposure ToInjuryProteinsFunctional DisorderBaseLinkVeteransVascular DementiaCerebrovascularDementiaAgingCerebrovascular DisordersPreventEndothelial DysfunctionIn VivoImpaired CognitionEndotheliumBrainAmyloidResponse
Grant awards (24)
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2025 · VA · contact PI
Discovering Novel Mechanisms and Treatment for Aging-Related Dementia: Probing Medin and Abeta Vasculopathy$0
I01 · FY2024 · VA · contact PI
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2024 · VA · contact PI
Understanding vascular aging-related dementia through medin signaling$471,635
R56 · FY2023 · AG · contact PI
Anti-medin immunotherapy for vascular aging and related dementias$380,060
R21 · FY2023 · AG · contact PI
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2023 · VA · contact PI
Discovering Novel Mechanisms and Treatment for Aging-Related Dementia: Probing Medin and Abeta Vasculopathy$0
I01 · FY2023 · VA · contact PI
Discovering the Origin of Vascular Aging Amyloid Protein Medin$347,379
R21 · FY2022 · AG
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2022 · VA · contact PI
Discovering Novel Mechanisms and Treatment for Aging-Related Dementia: Probing Medin and Abeta Vasculopathy$0
I01 · FY2022 · VA · contact PI
Discovering Novel Mechanisms and Treatment for Aging-Related Dementia: Probing Medin and Abeta Vasculopathy$0
I01 · FY2021 · VA · contact PI
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2021 · VA · contact PI
Discovering novel mechanisms for aging-related dementia: probing medin and abeta vasculopathy$0
I01 · FY2020 · VA · contact PI
Discovering novel mechanisms for aging-related dementia: probing medin and abeta vasculopathy$0
I01 · FY2019 · VA · contact PI
Discovering novel mechanisms for aging-related dementia: probing medin and abeta vasculopathy$0
I01 · FY2018 · VA · contact PI
Discovering novel mechanisms for aging-related dementia: probing medin and abeta vasculopathy$0
I01 · FY2017 · VA · contact PI
Human vascular model to study Alzheimer's Disease$153,138
R21 · FY2015 · AG · contact PI
Nanoliposome-based Treatment of Amyloid Protein (AL) Toxicity$0
I01 · FY2015 · VA · contact PI
Human vascular model to study Alzheimer's Disease$189,450
R21 · FY2014 · AG · contact PI
Nanoliposome-based Treatment of Amyloid Protein (AL) Toxicity$0
I01 · FY2014 · VA · contact PI
Nanoliposome-based Treatment of Amyloid Protein (AL) Toxicity$0
I01 · FY2013 · VA · contact PI
Vascular dysfunction and oxidative stress in primary amyloidosis$149,258
R21 · FY2010 · HL · contact PI
Vascular dysfunction and oxidative stress in primary amyloidosis$231,716
R21 · FY2009 · HL · contact PI
CARDIAC MRI IN DIAGNOSIS OF CARDIAC AMYLOIDOSIS (PILOT STUDY)$1,930
M01 · FY2006 · RR · contact PI